Edwards Lifesciences (EW) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $86.39 +1.38%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
SMXT, NRIX, VFS, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
GUIDANCE:
Edwards Lifesciences sees Q4 2021 EPS of $0.53-$0.59, versus the consensus of $0.56. Edwards Lifesciences sees Q4 2021 revenue of $1.3-1.38 billion, versus the consensus of $1.41 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Nexxen names Neil Jones interim board chair after AGM
- RBC Capital Downgrades Technology One Ltd (TNE:AU) to Sector Perform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
